BD Gains 510(k) Clearance of Artificial Intelligence Software for MRSA Diagnostics
BD Kiestra MRSA Imaging Application Helps Enhance Microbiology Laboratory Efficiency and Workflow
FRANKLIN LAKES, N.J., May 16, 2023 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical ... Diagnostics, FDA BD , BD Kiestra, artificial intelligence, MRSA
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Infectious Diseases | Laboratory Medicine | Marketing | Microbiology | MRSA | Pharmaceuticals | Superbugs